FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 651 through 671 of 671

COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH - SIC # 8731

Ticker Exchange Company Financial Reports SIC #
VYNE Nasdaq Vyne Therapeutics Inc 8731
WINT Nasdaq Windtree Therapeutics Inc 8731
WNDW Over the counter Solarwindow Technologies Inc 8731
WVE Nasdaq Wave Life Sciences Ltd 8731
XBIO Nasdaq Xenetic Biosciences Inc 8731
XCUR Nasdaq Exicure Inc 8731
XERS Nasdaq Xeris Biopharma Holdings Inc 8731
XFOR Nasdaq X4 Pharmaceuticals Inc 8731
XLO Nasdaq Xilio Therapeutics Inc 8731
XOMA Nasdaq XOMA Corp 8731
XRTX New York XORTX Therapeutics Inc 8731
XSNX Over the counter NovAccess Global Inc 8731
XTLB Nasdaq X T L Biopharmaceuticals Ltd ( 8731
XXII Nasdaq 22nd Century Group Inc 8731
YBGJ Over the counter Yubo International Biotech Ltd 8731
YMAB Nasdaq Y-mAbs Therapeutics Inc 8731
YTEN Nasdaq Yield10 Bioscience Inc 8731
ZEN New York Zentek Ltd 8731
ZURA Nasdaq Zura Bio Ltd 8731
ZVSA Nasdaq Zyversa Therapeutics Inc 8731
ZYME Nasdaq Zymeworks Inc 8731
Results 650 through 671 of 671